Journal of the Bahrain Medical Society

Year 2022, Volume 34, Issue 1, Pages 61-65

https://doi.org/10.26715/JBMS.34_2022_1_9

Case Report

Gastric Adenocarcinoma In A Young Adult Female

Zahra Sayed Alawi Mahfoodh1, Zahra Abdulla Hasan2, Sayed Dhiyaa Noor Ebrahim3*

Author Affiliation

1Resident Doctor, School of Medicine, Royal College of Surgeons in Ireland – MUB, Bahrain.

2Resident Doctor, Ibn Al Nafees Hospital, Royal College of Surgeons in Ireland – MUB, Bahrain.

3Resident Doctor, Ibn Al Nafees Hospital, Royal College of Surgeons in Ireland – MUB, Bahrain.

Corresponding author:

Dr. Sayed Dhiyaa Noor Ebrahim, Resident Doctor, Ibn Al Nafees Hospital, Royal College of Surgeons in Ireland – MUB, Bahrain; Email: drsdhiyaa@gmail.com

Received date: July 21, 2020; Accepted date: September 22, 2021; Published date: March 31, 2022


Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 2.0 Generic License .

Abstract

Malignancy is not frequently encountered among young adults and is thus at the bottom of the list of differential diagnoses. As a result, it can be overlooked or falsely diagnosed as another less-debilitating medical condition. A similar situation is presented in this paper. A young female presented with no risk factors or specific red-flag symptoms for malignancy, and the initial investigational findings strongly supported her presenting symptoms, which masked the main cause of her complaint.

Keywords: Abdominal pain, Adenocarcinoma, Biliary colic, Gallstones, Gastric cancer

Tables and Figures can be referred to in the PDF.


Introduction

Abdominal pain is a common symptom in patients and is routinely encountered in daily clinical practice. The causes and list of differential diagnoses are broad and vast, so a preliminary or a provisional diagnosis can be made depending on the pain’s severity, location, duration, and the presence of other associated symptoms.1 Fortunately, due to the latest and non-invasive diagnostic tests and imaging modalities, it is now possible to rule out serious etiologies in a matter of hours. However, we should always focus on the red-flag symptoms in patients’ medical histories, physical examinations, and initial laboratory values. A case is presented where evident physical symptoms were masked by other concomitant symptoms of similar nature and character.

Case report

A 30-year-old Bahraini female with a known case of Glucose – 6 Phosphate Dehydrogenase deficiency [G6PD] presented to our hospital with a history of abdominal pain associated with nausea for a duration of five months. The pain was predominantly in the right upper quadrant and radiated to the central back. It was intermittent in nature and aggravated by the intake of fatty food.

Epigastric tenderness with negative Murphy’s sign was the only notable point upon physical examination. The results of laboratory blood investigations were normal at this stage, including a complete blood count, liver function test, renal function test, electrolytes, and inflammatory markers. Furthermore, an abdominal ultrasound was Introduction Abdominal pain is a common symptom in patients and is routinely encountered in daily clinical practice. The causes and list of differential diagnoses are broad and vast, so a preliminary or a provisional diagnosis can be made depending on the pain’s severity, location, duration, and the presence of other associated symptoms.1 Fortunately, due to the latest and non-invasive diagnostic tests and imaging modalities, it is now possible to rule out serious etiologies in a matter of hours. However, we should always focus on the red-flag symptoms in patients’ medical histories, physical examinations, and initial laboratory values. A case is presented where evident physical symptoms were masked by other concomitant symptoms of similar nature and character.

Case report

A 30-year-old Bahraini female with a known case of Glucose – 6 Phosphate Dehydrogenase deficiency [G6PD] presented to our hospital with a history of abdominal pain associated with nausea for a duration of five months. The pain was predominantly in the right upper quadrant and radiated to the central back. It was intermittent in nature and aggravated by the intake of fatty food. Epigastric tenderness with negative Murphy’s sign was the only notable point upon physical examination. The results of laboratory blood investigations were normal at this stage, including a complete blood count, liver function test, renal function test, electrolytes, and inflammatory markers. Furthermore, an abdominal ultrasound was performed, which showed multiple tiny gallstones without cholecystitis. This finding fairly explained the patient’s experience of occasional biliary colic as a cause for her chronic intermittent abdominal pain at this stage. Accordingly, the patient underwent a laparoscopic cholecystectomy in the same month, with uneventful recovery.

After five months, the patient presented again with acute abdominal pain, and Computed Tomography (CT) of the abdomen was performed. The results suggested acute interstitial pancreatitis without necrosis or pseudocyst. Thus, the patient was admitted for further inpatient management. Magnetic Resonance Cholangiopancreatography (MRCP) was performed to investigate the cause of acute pancreatitis, which revealed choledocholithiasis of two stones measuring 3 and 4 mm each. Accordingly, Endoscopic Retrograde Cholangiopancreatography (ERCP) was performed for stone extraction, and the patient’s symptoms fully resolved.

Three months later, the patient presented once more to the emergency department with severe abdominal pain, vomiting, and obvious severe jaundice. No fever and no change in bowel habits were noted. Table 1 shows the result of the blood test performed during the third presentation that was showing mild anaemia, with significant hyperbilirubinemia and liver function derangement.

MRCP was repeated and showed no stones in the common bile duct. However, a thick stomach wall was incidentally noted. Accordingly, a gastroscopy was performed, which revealed diffuse gastric body mucosal infiltration with stiffness. This was highly suspicious for linitis plastica. Figure 1 shows images of the endoscopic findings. Accordingly, a biopsy was obtained and sent for histopathological study that confirmed the diagnosis of gastric adenocarcinoma. Table 2 presents the major histological findings. Finally, all investigational findings were explained to the patient, who chose to pursue treatment abroad, so follow-up contact was lost.

Discussion

Gastric cancer is considered the fifth most common type of cancer and the third leading cause of cancer death worldwide. A higher incidence is reported in older adults.1 The Surveillance, Epidemiology, and End Result: Cancer Statistics Review [SEER] confirms that more than 95% of newly diagnosed cases were in patients above the age of 40 years.2,3 Although the overall prevalence of gastric cancer has decreased in the past few decades, it has been noted that the rate has increased in younger adults.4

One study showed that 58% of young patients with gastric cancer do not present with alarm symptoms.5 In this age group, physicians may be misled by general gastrointestinal symptoms such as epigastric pain, as in our case, thus causing a delay in the diagnosis. The present patient also had gallstones, which were consistent with the clinical picture of the presenting symptoms. This may have also been a contributing factor to the delay of the diagnosis.

Various risk factors of gastric cancer have been presented in epidemiological studies, including H. pylori infection, which is considered as the main etiological factor in gastric carcinogenesis, dietary habits (such as higher intake of beef and barbecued/ smoked foods and a lower intake of fresh fruits/ vegetables) and lifestyle factors (such as smoking and alcohol drinking) are highly consistent with the risk of gastric cancer. Hereditary factors include hereditary diffuse gastric cancer (HDGC), hereditary nonpolyposis colorectal cancer, and familial adenomatous polyposis.6 None of these risk factors were present in our case. Considering gastric cancer as a differential diagnosis in young patients with gastro-intestinal symptoms is crucial in determining the disease early on.

There are two main classification systems for gastric carcinoma: World Health Organization and Lauren classification. Based on Lauren’s criteria, gastric carcinoma is classified histologically as two major subtypes: intestinal and diffuse-type adenocarcinoma.7 Both types exhibit numerous differences in pathology, epidemiology, and etiology. Clinically, the intestinal type of gastric cancer has been noted to occur more commonly in elderly male patients. In contrast, the diffuse subtype of gastric cancer is predominantly associated with young female patients, as in our case.8

As for etiology, the two subtypes have dietary and environmental risk factors in common. However, the intestinal type is more associated with environmental factors, while the diffuse type usually has a genetic etiology.9 In our case, no genetic or environmental risk factors were present. The World Health Organization classifies gastric adenocarcinoma into four major types: tubular, papillary, mucinous, and poorly cohesive carcinoma.10 Other uncommon histological variants are also included in the classification system.

The management plan for gastric carcinoma can vary based on the stage of the disease. Surgical intervention (radical gastrectomy) remains the gold standard of treatment for gastric cancer. However, it is curative in less than 40 percent of cases.11 Adjuvant radio-chemotherapy can be used to reduce the risk of recurrence or relapse and can improve the overall survival rate compared to surgery alone.11 This treatment method should be considered for patients with a high risk of relapse. In advanced stages of the disease, palliative chemotherapy is used as a first-line treatment. However, no standard international regimen has been approved for palliative chemotherapy in advanced stages of gastric cancer.12

The prognosis of gastric cancer in young patients compared to older adults remains controversial. Some studies have shown poorer prognoses in young patients compared to older adults, while others have shown similar survival rates between the two groups. The overall survival rate for both groups is low despite advances in diagnosis and treatment. The 5-year survival rate is estimated to be less than 30%.13-15

Conclusion

In conclusion, we have reported an unfortunate case of a young woman with an incidental finding of a thick stomach wall, that was discovered in Magnetic Resonance Imaging of the abdomen. Further investigation revealed an advance gastric adenocarcinoma. No data have been found regarding the prevalence or incidence of gastric cancer among the young adult population in Bahrain.

Despite the availability of the latest imaging and investigational modalities, it remains important to take a detailed medical history and to conduct a comprehensive physical examination as a cornerstone of clinical practice.

Conflict of Interest

All authors contributed equally to writing of this case report and the preparation of the final manuscript. The authors report no conflict of interest.

Source of funding

No funding was required

Acknowledgements

Not applicable

References

1. Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68:394–424.

2. Duggan M, Anderson W, Altekruse S, Penberthy L, Sherman M. The Surveillance, Epidemiology, and End Results (SEER) Program and Pathology: Toward Strengthening the Critical Relationship. Am J Surg Pathol. 2016;40(12):94-102.

3. De B, Rhome R, Jairam V, et al. Gastric adenocarcinoma in young adult patients: patterns of care and survival in the United States. Gastric Cancer. 2018;21(6):889-899

4. Pisanu, M Podda, A Cois, et al. Gastric cancer in the young: is it a different clinical entity? A retrospective cohort study. Gastroenterology Research and Practice. 2014; 2014:1-9

5. Maconi G, Kurihara H, Panizzo V, et al. Gastric cancer in young patients with no alarm symptoms: focus on delay in diagnosis, stage of neoplasm and survival. Scand J Gastroenterol. 2003;38(12):1249-1255.

6. Parsonnet J, Friedman G, Vandersteen D, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med. 1991; 325:1127–1131

7. Hwang SW, Lee DH, Lee SH, et al. Preoperative staging of gastric cancer by endoscopic ultrasonography and multidetectorrow computed tomography. J Gastroenterol Hepatol. 2010;25(3):512-8.

8. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histoclinical classification. Acta Pathol Microbiol Scand. 1965;64:31-49.

9. Ma J, Shen H, Kapesa L, et al. Lauren classification and individualized chemotherapy in gastric cancer. Oncol Lett. 2016;11(5):2959- 2964.

10. Lauwers GY, Carneiro F, Graham DY. Gastric carcinoma. Classification of Tumours of the Digestive System. Lyon: IARC; 2010.

11. Macdonald JS, Smalley SR, Benedetti J, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med. 2001;345(10):725-30.

12. Park SC, Chun HJ. Chemotherapy for advanced gastric cancer: review and update of current practices. Gut Liver. 2013;7(4):385-393.

13. Correa P. Gastric cancer: overview. Gastroenterol Clin North Am. 2013;42(2):211- 217.

14. Merchant SJ, Kim J, Choi AH, Sun V, Chao J, Nelson R. A rising trend in the incidence of advanced gastric cancer in young Hispanic men. Gastric Cancer. 2017;20(2):226–234.

15. Rawla P, Barsouk A. Epidemiology of gastric cancer: global trends, risk factors and prevention. Prz Gastroenterol. 2019;14(1):26- 38. doi:10.5114/pg.2018.80001